TL;DR
Results establish pyrazole–triazole Schiff bases as promising antimicrobial scaffolds, providing a rational basis for future pharmacological development and structural optimization.
It is suggested that thiazolo[5,4-b]pyridine–sulfonamide hybrids represent promising scaffolds for the development of new antimicrobial agents.
The results suggest that the thienopyrimidine–piperazine scaffold is a promising framework for the development of multifunctional therapeutic agents.
Findings position Schiff-base triazole hybrids as structurally versatile and biologically promising scaffolds, warranting accelerated pharmacological exploration toward the development of next-generation antimicrobial therapeutics.
The integration of experimental antimicrobial assessment with computational studies supports the pyrene–pyrazole framework as a promising scaffold for the further development of effective antimicrobial agents.
The determined biological activities of Schiff base derivatives obtained from 4-aminoantipyrine via condensation with various aromatic and heteroaromatic aldehydes support these derivatives as promising multifunctional scaffolds for the development of novel antibacterial and anticancer agents.
The results indicate that structural modification of sulfadiazine through heterocyclic ring formation significantly enhances antibacterial activity and binding affinity, suggesting their potential as promising antimicrobial agents.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
